2025-02-21 - Analysis Report
## UnitedHealth Group Inc (UNH) Stock Analysis

**0. Key Figures & Initial Analysis:**

UNH, UnitedHealth Group Inc., is a diversified healthcare company.  The provided data shows a significant outperformance compared to the S&P 500 (VOO) over the period analyzed, with a substantial cumulative return difference. However, recent performance has weakened, as indicated by moving averages and technical indicators.

**1. Performance Comparison with S&P 500 (VOO):**

* **UNH Cumulative Return:** 140.28%
* **VOO Cumulative Return:** 121.84%
* **Return Difference:** 18.44% (The relative divergence indicates this outperformance is in the upper 16.2% of historical observations.)

The provided Alpha and Beta analysis shows consistently positive alpha (outperformance relative to the market),  particularly strong from 2019-2022, but the recent period (2022-2025) indicates a significant negative CAGR.

**Table 1: Alpha and Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 58.0% | 1.8% | 30.0% | 0.1 | 182.9 |
| 2016-2018  | 66.0% | 10.5% | 47.0% | 0.1 | 209.5 |
| 2017-2019  | 52.0% | 10.5% | 21.0% | 0.3 | 251.4 |
| 2018-2020  | 32.0% | 10.5% | 5.0% | 0.3 | 304.8 |
| 2019-2021  | 96.0% | 9.4% | 26.0% | 0.3 | 442.6 |
| 2020-2022  | 102.0% | 5.5% | 93.0% | 0.3 | 473.3 |
| 2021-2023  | 60.0% | 5.5% | 37.0% | 0.3 | 477.0 |
| 2022-2024  | -24.0% | 16.6% | -57.0% | 0.3 | 465.5 |
| 2023-2025  | -14.0% | 16.6% | -77.0% | 0.2 | 481.8 |


**2. Recent Price Movement:**

* **Closing Price:** $523.51
* **5-Day Moving Average:** $529.88
* **20-Day Moving Average:** $533.44
* **60-Day Moving Average:** $540.37

The stock price is currently trading below all three moving averages, suggesting a bearish short-term trend.


**3. Technical Indicators:**

* **RSI:** 35.21  (Approaching oversold territory, suggesting potential for a bounce but also vulnerability)
* **PPO:** -0.25 (Negative value indicates bearish momentum)
* **20-Day Relative Divergence Change:** -3.5% (Short-term bearish trend)
* **Expected Return:** 411.5% (This high expected return needs further context.  It likely reflects the model's long-term outlook based on historical data, and may be unreliable given the recent downturn.)


**4. Recent Earnings Analysis:**

**Table 2: Recent Earnings**

| Date       | EPS      | Revenue           |
|------------|----------|--------------------|
| 2024-11-04 | $6.56    | $100.82 Billion   |
| 2024-08-09 | $4.58    | $98.86 Billion    |
| 2024-05-09 | -$1.53   | $99.80 Billion    |
| 2023-11-06 | $6.31    | $92.36 Billion    |
| 2024-11-04 | $6.31    | $92.36 Billion    | *(Duplicate Entry)*


Earnings show some volatility, with a significant loss in Q2 2024.  Revenue generally shows growth, but further analysis of profitability (missing gross profit and total revenue data) is needed. The duplicate entry needs clarification.


**5. Financial Information:**

The absence of total revenue and gross profit data severely limits a comprehensive financial analysis.  This crucial data is required to assess the company's profitability and financial health.


**6. Overall Analysis:**

UNH has historically outperformed the S&P 500, exhibiting strong alpha. However, recent performance is concerning, showing negative CAGR and trading below key moving averages.  Technical indicators suggest bearish momentum, although the RSI is approaching oversold levels.  The lack of complete financial data prevents a thorough assessment of the company's fundamentals.  The exceptionally high projected return needs significant caution and further investigation to assess its validity given recent negative trends. Before making any investment decision, it's crucial to obtain the missing financial data and conduct further analysis of the reasons for the recent downturn.
